M. Waheed Roomi
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 17
- Drug Transport and Resistance Mechanisms 7
- Peptidase Inhibition and Analysis 6
- Co-authors
- Tatiana Kalinovsky (40 shared papers)Matthias Rath (43 shared papers)Aleksandra Niedzwiecki (35 shared papers)Vadim Ivanov (18 shared papers)Emmanuel Farber (13 shared papers)E.H. Eylar (6 shared papers)D.S.R. Sarma (2 shared papers)A. Ishaque (4 shared papers)
- Journals
- International Journal of Oncology (9 papers)Oncology Reports (8 papers)Cancer Letters (3 papers)Toxicologic Pathology (3 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
M. Waheed Roomi
80 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Applied Microbiology and Biotechnology 65
- Pharmacology 182
- Cancer Research 261
- Biochemistry 99
- Biochemistry 97
Countries citing papers authored by M. Waheed Roomi
This map shows the geographic impact of M. Waheed Roomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Waheed Roomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Waheed Roomi more than expected).
Fields of papers citing papers by M. Waheed Roomi
This network shows the impact of papers produced by M. Waheed Roomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Waheed Roomi. The network helps show where M. Waheed Roomi may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Waheed Roomi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. | 1985 | 150 |
| 2 | 1980 | 83 | |
| 3 | 2013 | 66 | |
| 4 | 1978 | 63 | |
| 5 | 2005 | 57 | |
| 6 | In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. | 2005 | 49 |
| 7 | 1981 | 48 | |
| 8 | 2017 | 45 | |
| 9 | 1984 | 43 | |
| 10 | 2010 | 42 | |
| 11 | 2005 | 37 | |
| 12 | 1983 | 35 | |
| 13 | 1983 | 33 | |
| 14 | 2005 | 33 | |
| 15 | 2006 | 30 | |
| 16 | 1986 | 30 | |
| 17 | 2006 | 28 | |
| 18 | 1987 | 24 | |
| 19 | 2006 | 23 | |
| 20 | 1984 | 23 |
About M. Waheed Roomi
M. Waheed Roomi is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Epidemiology, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Tea Polyphenols and Effects (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Tannin, Tannase and Anticancer Activities (11 papers), Cancer Research and Treatments (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (65 citations), Pharmacology (182 citations), Cancer Research (261 citations), Biochemistry (99 citations) and Biochemistry (97 citations). M. Waheed Roomi has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Tatiana Kalinovsky, Matthias Rath, Aleksandra Niedzwiecki, Vadim Ivanov, Emmanuel Farber, E.H. Eylar, D.S.R. Sarma, A. Ishaque, Aleksandra Niedzwiecki and David M. Goldberg. Their work appears in journals such as International Journal of Oncology, Oncology Reports, Cancer Letters, Toxicologic Pathology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.